glp-1 gip 2ra Dual GIP/GLP-1 receptor agonists: New advances for treating type-2 diabetes Science Behind GLP 1 GIP

Description

Image Credit: Love Employee / Shutterstock In a recent study published in the journal BMJ Medicine , researchers conducted a target trial emulation to assess associations between different scenarios of glucagon-like peptide-1 receptor agonist (GLP-1RA) treatment and the risk of major adverse cardiovascular events (MACE)

One of the latest GLP-1 analogs under development is drawing particular attention by showing as many weight-reducing effects as obesity metabolic surgery, according to industry executives Friday

Incretin hormones: their role in health and disease

Since responses to treatment differ from person to person, personalized care is essential

Hence, these investigations illustrate that GLP-1R agonism effectively slows down the advancement of atherosclerosis through a glycemia-independent and endothelial GLP-1R-dependent pathway